Literature DB >> 24535817

Prospective cohort studies of association between family history of liver cancer and risk of liver cancer.

Yang Yang1, Qi-Jun Wu, Li Xie, Wong-Ho Chow, Nat Rothman, Hong-Lan Li, Yu-Tang Gao, Wei Zheng, Xiao-Ou Shu, Yong-Bing Xiang.   

Abstract

Uncertainty remains on the relationship between a family history of liver cancer and liver cancer risk in prospective cohort studies in a general population. Thus, we examined this association in 133,014 participants in the Shanghai Women's and Men's Health Studies. Family history of liver cancer was categorized through dichotomous and proportional score approaches. Hazard ratios (HRs) and 95% confidence intervals (CIs) were derived using the Cox proportional hazards models with adjustment for potential confounders. A meta-analysis of observational studies through December 2013 on liver cancer risk in relation to family history of liver cancer was also performed. Study-specific risk estimates were combined using fixed or random effects models depending on whether significant heterogeneity was detected. For the Shanghai Women's and Men's Health Studies, 299 liver cancer cases were identified during follow-up through 2010. Family history of liver cancer was associated with liver cancer risk using both binary indicator (HR = 2.60, 95% CI: 1.77-3.80) and proportional score (high-risk vs. minimal-risk category: HR = 3.03, 95% CI: 1.73-5.31), with increasing HRs for increasing score categories. The meta-analysis also showed an increased risk for those with a family history of liver cancer (relative risk = 2.55, 95% CI: 2.05-3.16). Family history of liver cancer was related to increased risk of liver cancer in Chinese population. This risk is particularly high for those with an affected mother. The "dose-response" of risk with an increasing family history score of liver cancer might further facilitate future cancer prevention programs on identifying individuals with the highest potential liver cancer risk.
© 2014 UICC.

Entities:  

Keywords:  cohort studies; family history of liver cancer; liver cancer; meta-analysis

Mesh:

Year:  2014        PMID: 24535817      PMCID: PMC4188921          DOI: 10.1002/ijc.28792

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  50 in total

1.  A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection.

Authors:  Zhong-Zheng Zhu; Wen-Ming Cong; Shu-Fang Liu; Zhi-Hong Xian; Wei-Qing Wu; Meng-Chao Wu; Bin Gao; Li-Fang Hou; Guan-Shan Zhu
Journal:  Cancer Lett       Date:  2005-11-08       Impact factor: 8.679

2.  A case-control study on family history of liver cancer as a risk factor for hepatocellular carcinoma in North Italy. Brescia HCC Study.

Authors:  F Donato; U Gelatti; R Chiesa; A Albertini; E Bucella; P Boffetta; A Tagger; M L Ribero; G Portera; M Fasola; G Nardi
Journal:  Cancer Causes Control       Date:  1999-10       Impact factor: 2.506

3.  [To investigate the relationship of alcohol intake and hepatocellular carcinoma among patients with hepatitis B virus infection].

Authors:  Gui-Ting Zhu; Guo-Qiang Lou; Jun-Ping Shi
Journal:  Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi       Date:  2011-10

4.  Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area.

Authors:  W-L Shih; M-W Yu; P-J Chen; S-H Yeh; M-T Lo; H-C Chang; Y-F Liaw; S-M Lin; C-J Liu; S-D Lee; C-L Lin; C K Hsiao; S-Y Yang; C-J Chen
Journal:  Oncogene       Date:  2006-05-25       Impact factor: 9.867

5.  The Shanghai Women's Health Study: rationale, study design, and baseline characteristics.

Authors:  Wei Zheng; Wong-Ho Chow; Gong Yang; Fan Jin; Nathaniel Rothman; Aaron Blair; Hong-Lan Li; Wanqing Wen; Bu-Tian Ji; Qi Li; Xiao-Ou Shu; Yu-Tang Gao
Journal:  Am J Epidemiol       Date:  2005-10-19       Impact factor: 4.897

6.  Polymorphism of T-cell receptor gamma short tandem repeats as a susceptibility risk factor of hepatocellular carcinoma.

Authors:  Li-Ming Hsu; Yi-Shin Huang; Shi-Yi Yang; Full-Young Chang; Shou-Dong Lee
Journal:  Anticancer Res       Date:  2006 Sep-Oct       Impact factor: 2.480

7.  The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States.

Authors:  Manal M Hassan; Margret R Spitz; Melanie B Thomas; Steven A Curley; Yehuda Z Patt; Jean-Nicolas Vauthey; Katrina Y Glover; Ahmed Kaseb; Richard D Lozano; Adel S El-Deeb; Nga T Nguyen; Steven H Wei; Wenyaw Chan; James L Abbruzzese; Donghui Li
Journal:  J Hepatol       Date:  2008-10-16       Impact factor: 25.083

8.  [Etiologic fraction and interaction of risk factors for primary hepatic carcinoma in Guangxi, China].

Authors:  Sheng-Kui Tan; Xiao-Qiang Qiu; Hong-Ping Yu; Xiao-Yun Zeng; Zeng-Ming Xiao; Lang Hu
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2008-03

9.  A case-control study of the relationship between hepatitis B virus DNA level and risk of hepatocellular carcinoma in Qidong, China.

Authors:  Tao-Tao Liu; Ying Fang; Hui Xiong; Tao-Yang Chen; Zheng-Pin Ni; Jian-Feng Luo; Nai-Qing Zhao; Xi-Zhong Shen
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

10.  Dietary patterns and their correlates among middle-aged and elderly Chinese men: a report from the Shanghai Men's Health Study.

Authors:  Hui Cai; Wei Zheng; Yong-Bing Xiang; Wang Hong Xu; Gong Yang; Honglan Li; Xiao Ou Shu
Journal:  Br J Nutr       Date:  2007-05-25       Impact factor: 3.718

View more
  7 in total

1.  Chronic hepatitis B and liver cancer risks among Asian immigrants in New York City: Results from a large, community-based screening, evaluation, and treatment program.

Authors:  Henry J Pollack; Simona C Kwon; Su H Wang; Laura C Wyatt; Chau Trinh-Shevrin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11       Impact factor: 4.254

2.  Family history of liver cancer may modify the association between HBV infection and liver cancer in a Chinese population.

Authors:  Xing Liu; Aileen Baecker; Ming Wu; Jin-Yi Zhou; Jie Yang; Ren-Qiang Han; Pei-Hua Wang; Zi-Yi Jin; Ai-Min Liu; Xiaoping Gu; Xiao-Feng Zhang; Xu-Shan Wang; Ming Su; Xu Hu; Zheng Sun; Gang Li; Alan Fu; Su Yon Jung; Lina Mu; Na He; Liming Li; Jin-Kou Zhao; Zuo-Feng Zhang
Journal:  Liver Int       Date:  2019-07-10       Impact factor: 5.828

3.  Familial Risks for Liver, Gallbladder and Bile Duct Cancers and for Their Risk Factors in Sweden, a Low-Incidence Country.

Authors:  Kari Hemminki; Kristina Sundquist; Jan Sundquist; Asta Försti; Vaclav Liska; Akseli Hemminki; Xinjun Li
Journal:  Cancers (Basel)       Date:  2022-04-12       Impact factor: 6.575

4.  Association of family history with long-term prognosis in patients undergoing liver resection of HBV-related hepatocellular carcinoma.

Authors:  Zhen-Li Li; Jun Han; Kai Liu; Hao Xing; Han Wu; Wan Yee Lau; Timothy M Pawlik; Chao Li; Ming-Da Wang; Jiong-Jie Yu; Meng-Chao Wu; Feng Shen; Tian Yang
Journal:  Hepatobiliary Surg Nutr       Date:  2019-04       Impact factor: 7.293

5.  The clinical behavior and survival of patients with hepatocellular carcinoma and a family history of the disease.

Authors:  Jihyun An; Seheon Chang; Ha Il Kim; Gi-Won Song; Ju Hyun Shim
Journal:  Cancer Med       Date:  2019-09-18       Impact factor: 4.452

6.  Cost-Sensitive KNN Algorithm for Cancer Prediction Based on Entropy Analysis.

Authors:  Chaohong Song; Xinran Li
Journal:  Entropy (Basel)       Date:  2022-02-08       Impact factor: 2.524

7.  Risk prediction models for hepatocellular carcinoma in different populations.

Authors:  Xiao Ma; Yang Yang; Hong Tu; Jing Gao; Yu-Ting Tan; Jia-Li Zheng; Freddie Bray; Yong-Bing Xiang
Journal:  Chin J Cancer Res       Date:  2016-04       Impact factor: 5.087

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.